Virtually Assisted Home Rehabilitation After Stroke for Underserved Texas Communities (VAST TX)
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Sean Savitz, MD
- 電話番号:(713) 500-7083
- メール:Sean.I.Savitz@uth.tmc.edu
研究連絡先のバックアップ
- 名前:Tolulope Fashina
- 電話番号:713-500-7914
- メール:tolulope.fashina@uth.tmc.edu
研究場所
-
-
Texas
-
Houston、Texas、アメリカ、77030
- The University of Texas Health Science Center at Houston
-
コンタクト:
- Sean Savitz, MD
- 電話番号:(713) 500-7083
- メール:Sean.I.Savitz@uth.tmc.edu
-
コンタクト:
- Emily Stevens
- 電話番号:713-500-7914
- メール:emily.a.stevens@uth.tmc.edu
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Hospital admission with primary ICD-10 discharge diagnosis of Acute Ischemic Stroke (AIS) or Intracerebral Hemorrhage (ICH)
o those being referred from the community settings must be within 60 days of post-acute discharge.
- Post-stroke functional deficits warranting PASUC rehabilitation
- Clinically stable and appropriate for discharge per acute care facility
- Completion of a rehabilitation evaluation within the acute setting
- Planned discharge to home (with or without Home Health (HH)/Outpatient Rehabilitation (OPR), Inpatient Rehabilitation Facility (IRF), or Skilled Nursing Facility (SNF)
- Ability to speak and read English or Spanish
Ability to provide informed consent (patient or LAR)
o If LAR is consenting, patient must be able to follow simple commands
- Access to a video-capable device and internet
Exclusion Criteria:
- Clinically unstable medical condition
- Poorly controlled severe mental illness
- Planned discharge to a long-term care facility (LTACH)
- Inability to complete follow-up (psychiatric hospitalization, hospice, incarceration, homelessness)
- Discharge against medical advice
- Significant language impairment (NIHSS Commands >1 or Best Language >2)- Cognitive impairment (Six-Item, PROMIS) -Severe depression (PHQ-8 >20 or psychiatric hospitalization previous 30 days)- Pre-stroke mRS >3
- Other neurological or musculoskeletal conditions substantially limiting participation o Patients excluded for one of these criteria may be reassessed at 60-days to see if improvement has occurred.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:VAST + PASUC
|
Participants will receive a planned 4-week, home-based telerehabilitation (TR) intervention that integrates discipline-specific rehabilitation therapy with embedded self management health coaching
Participants will receive physical therapy, occupational therapy, speech and language therapy, and medical/nursing care aimed at improving functional mobility, activities of daily living, communication, and overall independence.
Rehabilitation is individualized based on patient needs and delivered in a supervised clinical setting.
|
|
アクティブコンパレータ:PASUC alone
|
Participants will receive physical therapy, occupational therapy, speech and language therapy, and medical/nursing care aimed at improving functional mobility, activities of daily living, communication, and overall independence.
Rehabilitation is individualized based on patient needs and delivered in a supervised clinical setting.
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in perceived ability to perform activities of daily living and functional mobility as assessed by the Stroke Impact Scale (SIS)-Activity subscale
時間枠:Baseline, 6 weeks, 18 weeks
|
This is scored from ange 0-100, with higher scores indicating better function
|
Baseline, 6 weeks, 18 weeks
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in impact of stroke as assessed by the Stroke Impact Scale (SIS)SIS domains (strength, mobility, hand function, communication, emotion, memory/thinking, and participation roles)
時間枠:baseline, 6 weeks, 18 weeks
|
This is a A 59 item questionnaire whereby subjects identify the impact of stroke on strength, mobility, hand function, communication, emotion, memory/thinking, and participation roles.
Item responses are scored on a 5-point Likert-style scale.
A score of 1 = an inability to complete the item and a score of 5 = no difficulty experienced at all.
A standardized score ranging from 0 to 100 is calculated for all domains, with higher scores indicating a higher quality of life
|
baseline, 6 weeks, 18 weeks
|
|
Change in degree of disability or dependence as measured by the Modified Rankin Score(mRS)
時間枠:Baseline, 6 weeks, 18 weeks
|
mRS is a 6 point disability scale with possible scores from 0(no disability) to 5(disability requiring constant care) a higher score indicating more disability
|
Baseline, 6 weeks, 18 weeks
|
|
Change in functional arm movements as assessed by the Fugl Meyer-Upper Extremity Assessment
時間枠:Baseline, 6 weeks,18 weeks
|
This is a 66 item questionnaire and each is scored from 0(cannot perform)-2(performs fully) a higher score indicating better outcome
|
Baseline, 6 weeks,18 weeks
|
|
Change in lower extremity functional strength as assessed by the Five Times Sit-to-Stand Test (5xSTS)
時間枠:Baseline, 6 weeks, 18 weeks
|
Participants will be instructed to rise from a seated position to standing and return to sitting five consecutive times as quickly as possible without using their upper extremities, if able.
Shorter completion times indicate better functional performance and lower extremity strength.
|
Baseline, 6 weeks, 18 weeks
|
|
Change in functional mobility as assessed by the Timed Up and Go (TUG) test
時間枠:Baseline, 6 weeks, 18 weeks
|
Participants will be instructed to stand up from a standard chair, walk 3 meters, turn around, walk back to the chair, and sit down.
Shorter completion times indicate better functional mobility and dynamic balance.
|
Baseline, 6 weeks, 18 weeks
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Sean Savitz, MD、The University of Texas Health Science Center, Houston
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- HSC-MS-26-0119
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。